Pulmonx (NASDAQ:LUNG) Price Target Cut to $15.00 by Analysts at Canaccord Genuity Group
Pulmonx (NASDAQ:LUNG – Get Free Report) had its price objective decreased by investment analysts at Canaccord Genuity Group from $16.00 to $15.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 297.88% from […]
Pulmonx (NASDAQ:LUNG – Get Free Report) had its price objective decreased by investment analysts at Canaccord Genuity Group from $16.00 to $15.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 297.88% from […]
